QTRX
Quanterix Corp

1,104
Mkt Cap
$353.13M
Volume
568,710.00
52W High
$12.41
52W Low
$4.05
PE Ratio
-3.18
QTRX Fundamentals
Price
$7.41
Prev Close
$7.56
Open
$7.63
50D MA
$6.14
Beta
1.68
Avg. Volume
780,301.21
EPS (Annual)
-$1.00
P/B
1.10
Rev/Employee
$291,764.33
Loading...
Loading...
News
all
press releases
Quanterix (QTRX) Projected to Post Earnings on Monday
Quanterix (NASDAQ:QTRX) will be releasing earnings before the market opens on Monday, December 22. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-12-22-quanterix-co-stock...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Quanterix (NASDAQ:QTRX) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen raised Quanterix from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·3d ago
News Placeholder
Quanterix Corporation (NASDAQ:QTRX) Given Consensus Recommendation of "Hold" by Analysts
Quanterix Corporation (NASDAQ:QTRX - Get Free Report) has earned an average rating of "Hold" from the five ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research...
MarketBeat·4d ago
News Placeholder
Russell Investments Group Ltd. Has $2.82 Million Stock Holdings in Quanterix Corporation $QTRX
Russell Investments Group Ltd. lowered its holdings in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) by 30.0% in the second quarter, according to its most recent 13F filing with the...
MarketBeat·7d ago
News Placeholder
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of...
Business Wire·25d ago
News Placeholder
Quanterix Corporation $QTRX Stock Holdings Decreased by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. lessened its position in Quanterix Corporation (NASDAQ:QTRX - Free Report) by 53.7% in the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·26d ago
News Placeholder
Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the publication of a landmark study in...
Business Wire·28d ago
News Placeholder
Quanterix (NASDAQ:QTRX) Issues Quarterly Earnings Results, Misses Estimates By $0.13 EPS
Quanterix (NASDAQ:QTRX - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.13...
MarketBeat·1mo ago
News Placeholder
Quanterix Corp Q3 Loss Increases, Misses Estimates
(RTTNews) - Quanterix Corp (QTRX) revealed Loss for its third quarter that increased from last year and missed the Street estimates...
Nasdaq News: Markets·1mo ago
News Placeholder
Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
<
1
2
...
>

Latest QTRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.